1                      The antitumor effect of immuno- and chemotherapeutic agents is executed through

2 egy opens a new venue for the combination of immuno- and chemotherapies.

3 as inhibitors that noncovalently block human immuno- and constitutive proteasomes.

4 gs and used as fluorescent analog tracers in immuno- and DNA probe assays as well as in cell and mole

5 imple, easy to use, low-cost, ultrasensitive immuno- and DNA probe assays can be developed using ligh

6  additional in vitro and in vivo specialized immuno- and hematotoxicity tests.

7 be rational to combine COX-2 inhibition with immuno- and immunogene therapy approaches (perhaps in co

8                          By using a combined immuno- and LC-MS-based assay we identify several major

9  issues that have undermined the efficacy of immuno- and virotherapy to date.

10 , and IL-10R blockade represents a potential immuno- and/or immunochemotherapeutic approach in this i

11                                              Immuno-, and cytohistochemistry was performed to validat

12              The integrase proteins of human immuno- deficiency virus type 1, visna virus, and Rous s

13                                              Immuno- deficient Scid-/- mice that have the wild-type T

14 on and neurodegeneration were accessible to (immuno-) histochemical methods as well as to in vivo met

15                                              Immuno- precipitated FKBP12-rapamycin-associated protein